Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: The risk for celiac disease after Covid-19 infection

Fig. 1

The yearly incidence of biopsy- and serology-verified celiac disease (CD) decreased from 2016 to 2021 (p = 0.046), as did the frequency of first-time positive tissue transglutaminase antibody (tTG-ab) tests (p = 0.015) and the number of cases with the combined outcome measure of either verified CD or positive tTG-ab (p = 0.006). Bars indicate 95% confidence intervals

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us